BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  GPC Biotech AG Release: New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th American Society of Clinical Oncology Annual Meeting

  June 2, 2008

   · 

  1 min read
• Drug Development

  GPC Biotech AG Says Satraplatin Didn’t Boost Survival in Study

  June 2, 2008

   · 

  7 min read
• Drug Development

  Celgene Corporation Release: Updated REVLIMID(R) Results Presented In Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL) at American Society of Clinical Oncology

  June 2, 2008

   · 

  1 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at American Society of Clinical Oncology Meeting in Chicago, Illinois

  June 2, 2008

   · 

  6 min read
• Drug Development

  IDM Pharma, Inc. Announces Phase 2 Follow-Up Data Showing IDM-2101 Is Well Tolerated With Positive Survival Trend In Non-Small Cell Lung Cancer Patients - Data Presented At 44th American Society of Clinical Oncology Annual Meeting Further Supports Improve

  June 2, 2008

   · 

  4 min read
• Drug Development

  Amgen Release: Updated Data from Ongoing Phase 3 Trials Support the Continued Study of Vectibix® (panitumumab) in Combination with Standard Chemotherapy

  June 2, 2008

   · 

  1 min read
• Multi Million Dollar Funding Package for Acculis Limited Microwave Cancer Treatment

  June 2, 2008

   · 

  1 min read
• Drug Development

  AMAG Pharmaceuticals, Inc. Announces Presentation of Positive Results from Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement Therapy in Kidney Transplant Recipients at the American Transplant Congress

  June 2, 2008

   · 

  1 min read
• Drug Development

  The Myelodysplastic Syndromes (MDS) Foundation Release: Data Presented at This Year’s American Society of Clinical Oncology Meeting Provide New Insights into the Treatment of Patients with Myelodysplastic Syndromes

  June 2, 2008

   · 

  1 min read
• Drug Development

  Phase III Study of Abbott Laboratories’ Investigational TriLipix(TM) in Combination With AstraZeneca Pharmaceuticals LP’s CRESTOR(R) Meets Primary Endpoints on Key Lipids

  June 2, 2008

   · 

  4 min read